Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 11 min ago
Peer-reviewedCC BYFrontiers in immunology

Context-dependent value of HLA class I diversity in advanced non-small cell lung cancer treated with immune checkpoint blockade

  1. 1Cancer Area, Health Research Institute Hospital 12 de Octubre (lmas 12) , ,
  2. 2Medical Oncology Department, 12 de Octubre Hospital , ,

Related

  1. Patient-Derived Melanoma Organoids Preserve Tumor-Immune Heterogeneity and Reveal Context-Dependent Responses to Immune Checkpoint Blockade
    M. Serasanambati, J. Chadokiya, M. Nakano +8
    bioRxivPreprintAll rights reservedFull textImmunologybioRxiv
  2. All of Us diversity and scale yield context-dependent improvements in polygenic prediction
    Kristin Tsuo, Zhuozheng Shi, Tian Ge +6
    Nature GeneticsPeer-reviewedLicence not stated24 citedGenetics & genomicsOpenAlex
  3. 951 Engineered tumor-homing bacteria enable systemic combination immune checkpoint blockade and cytokine immunotherapy
    Zongqi Wang, Jiahe Li
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYFull textSystems & synthetic biologyDOAJ
  4. Redox Storm in the Tumor Microenvironment (ΤΜΕ): Multifaceted Redox Injury and Immunometabolic Reprogramming Induced by Immune Checkpoint Blockade in B16F10 Melanoma: An Ultrastructural Study of the Peritumoral Interface
    Vasileios Alexandros Karakousis, Antonia Sioga, Ioannis S. Vizirianakis +4
    CellsPeer-reviewedCC BYFull textCell biologyEurope PMC
  5. 733 Macrophage-dendritic cell-T-cell tetrads orchestrate antitumor immunity and response to checkpoint blockade
    Xi Chen, Padmanee Sharma, James P Allison +15
    Journal for ImmunoTherapy of CancerPeer-reviewedCC BYFull textImmunologyDOAJ
BibTeX
@article{ramosparadas2026contextdependent,
  title = {{Context-dependent value of HLA class I diversity in advanced non-small cell lung cancer treated with immune checkpoint blockade}},
  author = {Javier Ramos-Paradas and Nuria Carrizo and Eva Álvarez and Cristina Martín-Arriscado and Mar López and Nieves Ortiz and Mercedes Herrera and Macarena Rey and Javier Baena and Jon Zugazagoitia and Luis Paz-Ares and Álvaro C. Ucero},
  journal = {Frontiers in immunology},
  year = {2026},
  month = oct,
  url = {https://europepmc.org/article/PMC/PMC13658205},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Context-dependent value of HLA class I diversity in advanced non-small cell lung cancer treated with immune checkpoint blockade
AU  - Javier Ramos-Paradas
AU  - Nuria Carrizo
AU  - Eva Álvarez
AU  - Cristina Martín-Arriscado
AU  - Mar López
AU  - Nieves Ortiz
AU  - Mercedes Herrera
AU  - Macarena Rey
AU  - Javier Baena
AU  - Jon Zugazagoitia
AU  - Luis Paz-Ares
AU  - Álvaro C. Ucero
PY  - 2026
DA  - 2026/10/16
JO  - Frontiers in immunology
UR  - https://europepmc.org/article/PMC/PMC13658205
SN  - 1664-3224
ER  -